A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Fisher Asset Management, LLC holds 8,271,606 shares of EW stock, worth $550 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
8,271,606
Previous 7,626,878 8.45%
Holding current value
$550 Million
Previous $729 Million 4.83%
% of portfolio
0.33%
Previous 0.34%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $54.4 Million - $60.8 Million
644,728 Added 8.45%
8,271,606 $764 Million
Q1 2024

May 09, 2024

BUY
$72.54 - $95.56 $36.2 Million - $47.6 Million
498,599 Added 6.99%
7,626,878 $729 Million
Q4 2023

Mar 05, 2024

SELL
$61.71 - $77.76 $346,378 - $436,466
-5,613 Reduced 0.08%
7,128,279 $544 Million
Q4 2023

Feb 06, 2024

SELL
$61.71 - $77.76 $11.1 Million - $14 Million
-180,575 Reduced 2.47%
7,133,892 $544 Million
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $48.9 Million - $65.8 Million
-705,173 Reduced 8.79%
7,314,467 $507 Million
Q2 2023

Dec 12, 2023

BUY
$81.41 - $94.33 $57.3 Million - $66.3 Million
703,324 Added 9.62%
8,017,791 $756 Million
Q2 2023

Aug 08, 2023

BUY
$81.41 - $94.33 $16.5 Million - $19.1 Million
202,581 Added 2.59%
8,019,640 $756 Million
Q1 2023

Dec 12, 2023

BUY
$74.26 - $84.51 $37.5 Million - $42.7 Million
505,072 Added 6.91%
7,819,539 $647 Million
Q1 2023

May 01, 2023

BUY
$74.26 - $84.51 $10.7 Million - $12.2 Million
144,441 Added 1.88%
7,817,059 $647 Million
Q4 2022

Feb 03, 2023

BUY
$68.3 - $87.44 $9.14 Million - $11.7 Million
133,880 Added 1.78%
7,672,618 $572 Million
Q3 2022

Nov 08, 2022

BUY
$82.37 - $107.29 $17.1 Million - $22.3 Million
208,057 Added 2.84%
7,538,738 $623 Million
Q2 2022

Aug 09, 2022

BUY
$86.5 - $128.27 $19.7 Million - $29.2 Million
227,736 Added 3.21%
7,330,681 $697 Million
Q1 2022

May 05, 2022

BUY
$101.96 - $128.34 $32.7 Million - $41.2 Million
320,643 Added 4.73%
7,102,945 $836 Million
Q4 2021

Feb 02, 2022

BUY
$106.37 - $130.68 $38 Million - $46.7 Million
357,605 Added 5.57%
6,782,302 $879 Million
Q3 2021

Oct 26, 2021

BUY
$102.91 - $122.75 $27.5 Million - $32.8 Million
267,356 Added 4.34%
6,424,697 $727 Million
Q2 2021

Jul 27, 2021

BUY
$83.84 - $104.76 $28.1 Million - $35.1 Million
334,627 Added 5.75%
6,157,341 $638 Million
Q1 2021

Apr 27, 2021

BUY
$78.68 - $90.67 $19.2 Million - $22.1 Million
244,081 Added 4.38%
5,822,714 $487 Million
Q4 2020

Jan 29, 2021

BUY
$71.69 - $91.23 $27.7 Million - $35.2 Million
386,233 Added 7.44%
5,578,633 $509 Million
Q3 2020

Nov 10, 2020

BUY
$67.19 - $87.44 $13.8 Million - $17.9 Million
204,982 Added 4.11%
5,192,400 $414 Million
Q2 2020

Aug 07, 2020

BUY
$57.54 - $76.95 $209 Million - $280 Million
3,632,715 Added 268.16%
4,987,418 $345 Million
Q1 2020

Apr 28, 2020

BUY
$52.41 - $81.0 $70.6 Million - $109 Million
1,346,783 Added 17004.84%
1,354,703 $256 Million
Q4 2019

Feb 12, 2020

SELL
$71.7 - $82.09 $96,508 - $110,493
-1,346 Reduced 14.53%
7,920 $1.85 Million
Q3 2019

Oct 29, 2019

BUY
$61.55 - $75.43 $131,778 - $161,495
2,141 Added 30.05%
9,266 $2.04 Million
Q2 2019

Jul 30, 2019

BUY
$55.74 - $64.41 $397,147 - $458,921
7,125 New
7,125 $1.32 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.